Form S-3 Arbutus Biopharma Corp
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Arbutus Biopharma (ABUS) Files $250M Mixed Shelf
November 4, 2021 5:12 PM EDTArbutus Biopharma (NASDAQ: ABUS) files $250,000,000 mixed shelf of:
Common Shares
Preferred Shares
Warrants
Debt Securities
Units
